Correlation Between Sonoma Pharmaceuticals and China Pharma
Can any of the company-specific risk be diversified away by investing in both Sonoma Pharmaceuticals and China Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonoma Pharmaceuticals and China Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonoma Pharmaceuticals and China Pharma Holdings, you can compare the effects of market volatilities on Sonoma Pharmaceuticals and China Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonoma Pharmaceuticals with a short position of China Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonoma Pharmaceuticals and China Pharma.
Diversification Opportunities for Sonoma Pharmaceuticals and China Pharma
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between Sonoma and China is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Sonoma Pharmaceuticals and China Pharma Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China Pharma Holdings and Sonoma Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonoma Pharmaceuticals are associated (or correlated) with China Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China Pharma Holdings has no effect on the direction of Sonoma Pharmaceuticals i.e., Sonoma Pharmaceuticals and China Pharma go up and down completely randomly.
Pair Corralation between Sonoma Pharmaceuticals and China Pharma
Given the investment horizon of 90 days Sonoma Pharmaceuticals is expected to generate 1.02 times more return on investment than China Pharma. However, Sonoma Pharmaceuticals is 1.02 times more volatile than China Pharma Holdings. It trades about -0.01 of its potential returns per unit of risk. China Pharma Holdings is currently generating about -0.05 per unit of risk. If you would invest 321.00 in Sonoma Pharmaceuticals on August 28, 2024 and sell it today you would lose (28.00) from holding Sonoma Pharmaceuticals or give up 8.72% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 97.67% |
| Values | Daily Returns |
Sonoma Pharmaceuticals vs. China Pharma Holdings
Performance |
| Timeline |
| Sonoma Pharmaceuticals |
| China Pharma Holdings |
Sonoma Pharmaceuticals and China Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sonoma Pharmaceuticals and China Pharma
The main advantage of trading using opposite Sonoma Pharmaceuticals and China Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonoma Pharmaceuticals position performs unexpectedly, China Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Pharma will offset losses from the drop in China Pharma's long position.| Sonoma Pharmaceuticals vs. China Pharma Holdings | Sonoma Pharmaceuticals vs. Universe Pharmaceuticals | Sonoma Pharmaceuticals vs. Akanda Corp | Sonoma Pharmaceuticals vs. Petros Pharmaceuticals |
| China Pharma vs. Capricor Therapeutics | China Pharma vs. Soleno Therapeutics | China Pharma vs. Bio Path Holdings | China Pharma vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |